These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 31427735)
21. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p. Zhang J; Furuta T; Sabit H; Tamai S; Jiapaer S; Dong Y; Kinoshita M; Uchida Y; Ohtsuki S; Terasaki T; Zhao S; Nakada M Cancer Sci; 2020 Jul; 111(7):2413-2422. PubMed ID: 32324311 [TBL] [Abstract][Full Text] [Related]
22. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20. Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442 [TBL] [Abstract][Full Text] [Related]
23. Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression. Gao YT; Chen XB; Liu HL Sci Rep; 2016 Sep; 6():32972. PubMed ID: 27595933 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1. Guo X; Piao H; Zhang Y; Sun P; Yao B Bosn J Basic Med Sci; 2020 Nov; 20(4):459-470. PubMed ID: 31999936 [TBL] [Abstract][Full Text] [Related]
25. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734 [TBL] [Abstract][Full Text] [Related]
26. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme. Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098 [TBL] [Abstract][Full Text] [Related]
27. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108 [TBL] [Abstract][Full Text] [Related]
28. CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis. Liu R; Dai W; Wu A; Li Y BMC Cancer; 2021 Oct; 21(1):1090. PubMed ID: 34627193 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR. Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954 [TBL] [Abstract][Full Text] [Related]
30. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1. Jia B; Liu W; Gu J; Wang J; Lv W; Zhang W; Hao Q; Pang Z; Mu N; Zhang W; Guo Q Exp Cell Res; 2019 Feb; 375(1):73-81. PubMed ID: 30586549 [TBL] [Abstract][Full Text] [Related]
31. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161 [No Abstract] [Full Text] [Related]
32. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2. Qi J; Pan L; Yu Z; Ni W Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848 [TBL] [Abstract][Full Text] [Related]
33. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway. Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814 [TBL] [Abstract][Full Text] [Related]
35. The CEBPB Yang Y; Jin X; Xie Y; Ning C; Ai Y; Wei H; Xu X; Ge X; Yi T; Huang Q; Yang X; Jiang T; Wang X; Piao Y; Jin X Theranostics; 2024; 14(10):4107-4126. PubMed ID: 38994023 [No Abstract] [Full Text] [Related]
36. Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma. Hu Z; You L; Hu S; Yu L; Gao Y; Li L; Zhang S Int Immunopharmacol; 2024 Jan; 126():111149. PubMed ID: 38006750 [TBL] [Abstract][Full Text] [Related]
37. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732 [TBL] [Abstract][Full Text] [Related]
38. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression. Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167 [TBL] [Abstract][Full Text] [Related]
39. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma. Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259 [TBL] [Abstract][Full Text] [Related]
40. Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme. Cheray M; Etcheverry A; Jacques C; Pacaud R; Bougras-Cartron G; Aubry M; Denoual F; Peterlongo P; Nadaradjane A; Briand J; Akcha F; Heymann D; Vallette FM; Mosser J; Ory B; Cartron PF Mol Cancer; 2020 Feb; 19(1):36. PubMed ID: 32098627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]